The Democratic Republic of Congo will receive 70,000 doses of the Ebola vaccine Ervebo for limited use and a clinical trial. WHO says 20,000 doses will be used in a Phase 3 trial to test protection against the Bundibugyo strain, while 50,000 doses will go to frontline and health workers.
Reporting from 5 identified publishers across this event arc.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 9098 of 21549
Same format. Every time.
Continue reading — sign in or create a free account with
